Company Filing History:
1 out of 320 
1 out of 1 Years Active: 2015
Title: The Innovative Contributions of Anne-Cécile V Bayne
Introduction
Anne-Cécile V Bayne is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of biotechnology, particularly in the production of proteins using microalgae. His work has implications for vaccine development and other biotechnological applications.
Latest Patents
Anne-Cécile V Bayne holds a patent for the "Production of hemagglutinin-neuraminidase protein in microalgae." This invention focuses on recombinant microalgal cells and their use in producing heterologous hemagglutinin-neuraminidase (HN) polypeptides. The patent outlines various compositions and uses of these proteins, showcasing the potential for advancements in vaccine technology.
Career Highlights
Throughout his career, Anne-Cécile has worked with prominent companies in the biotechnology sector. He has been associated with Merial Limited and Sanofi Vaccine Technologies, S.a.s., where he contributed to various innovative projects. His experience in these organizations has helped him develop a strong foundation in the field of vaccine research and development.
Collaborations
Anne-Cécile has collaborated with notable individuals in his field, including James Casey Lippmeier and Kirk Emil Apt. These collaborations have further enriched his research and contributed to the advancement of biotechnological innovations.
Conclusion
Anne-Cécile V Bayne's work exemplifies the intersection of innovation and biotechnology. His contributions, particularly in the production of hemagglutinin-neuraminidase proteins, highlight the potential of microalgae in vaccine development. His career reflects a commitment to advancing scientific knowledge and practical applications in the field.